CochLear Ltd. Unsponsored ADR (CHEOY) – What Are Analysts Saying About This Stock?

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) has received an average rating of “Hold” from the five ratings firms that are currently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold rating. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $117.00.

Several brokerages recently issued reports on CHEOY. Royal Bank Of Canada lowered CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target on the stock. in a research note on Thursday, July 16th. Jefferies Financial Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Finally, Canaccord Genuity Group cut CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th.

CochLear Trading Down 0.4%

OTCMKTS:CHEOY opened at $49.11 on Friday. CochLear has a one year low of $31.82 and a one year high of $98.29. The company has a fifty day moving average price of $48.12 and a 200 day moving average price of $52.39.

CochLear Company Profile

Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its portfolio includes cochlear implants, bone conduction implants and related sound processors, accessories and connectivity products designed to help users hear in a range of environments.

The company also provides clinical support, rehabilitation resources, software, technical services and ongoing care for recipients, clinicians and hearing professionals.